The Many Faces of B Cells
Experimental therapy prompts a closer look at immune cells
Five years ago, just as the global economy plummeted, interest in B cells spiked upward among...
Laboratory Research
Editors' Pick
Oral Laquinimod May Reduce Destructive Pathology in RRMS
Laquinimod appears to reduce brain MRI findings of inflammatory destruction in relapsing-remitting multiple sclerosis
Treatment with oral laquinimod may reduce MRI evidence of destructive brain pathology in...
Clinical Research, Drug Development
Career Opportunity: Senior Director, International Research Programs
National Multiple Sclerosis Society
New York City preferred
Posted:
23 Sep 2013
Papers: 13 Sep 2013 - 20 Sep 2013
New Funding Opportunities: Challenge Awards and Infrastructure Awards Deadline - January 31, 2014
Dear Colleagues:
The Progressive MS Alliance (previously known as the International Progressive MS Collaborative) is working together to find answers and develop solutions to end progressive MS. The Alliance aims to build upon current research efforts and connect resources and experts around the world.
Cutting-Edge Brain Science by UCSF Researcher Wins First Barancik Prize for Innovation in Multiple Sclerosis Research
-- Dr. Jonah Chan wins for creating cutting-edge and cost-effective technologies to solve the challenge of brain repair for people with MS
European Commission Approves Alemtuzumab (Lemtrada)
This follows the Commission's August 30 approval of teriflunomide (Aubagio).
Single Calcitriol Dose Beats Back EAE in Mice
Vitamin D zaps inflammatory T cells in the CNS and leads to sustained remission
Just a single dose of calcitriol—the active form of vitamin D—reversed...
Laboratory Research
Pages
